Papers - OOSATO AYAKO
-
Therapeutic reference range for plasma concentrations of paroxetine in patients with major depressive disorders.
Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, Kazuhiko Nakamura, Sunao Kaneko
Therapeutic drug monitoring 36 ( 4 ) 480 - 485 2014.8
-
An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder.
Tetsu Tomita, Masamichi Ishioka, Ayako Kaneda, Norio Sugawara, Taku Nakagami, Kazuhiko Nakamura, Norio Yasui-Furukori
Journal of affective disorders 165 109 - 113 2014.8
-
Sex-specific effects of subjective memory complaints with respect to cognitive impairment or depressive symptoms.
Tetsu Tomita, Norio Sugawara, Ayako Kaneda, Noriyuki Okubo, Kaori Iwane, Ippei Takahashi, Sunao Kaneko, Norio Yasui-Furukori
Psychiatry and clinical neurosciences 68 ( 3 ) 176 - 181 2014.3
-
The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects - a preliminary study.
Masamichi Ishioka, Norio Sugawara, Ayako Kaneda, Noriyuki Okubo, Kaori Iwane, Ippei Takahashi, Norio Yasui-Furukori
Neuropsychiatric disease and treatment 10 1721 - 1725 2014
-
A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan.
Koji Tsuruga, Norio Sugawara, Norio Yasui-Furukori, Ippei Takahashi, Shoko Tsuchimine, Ayako Kaneda, Shigeyuki Nakaji, Kazuhiko Nakamura
Neuropsychiatric disease and treatment 10 1621 - 1627 2014
-
The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, Norio Sugawara, Sunao Kaneko
PloS one 9 ( 5 ) e98099 - e98099 2014
-
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response.
Tetsu Tomita, Norio Yasui-Furukori, Yasui-Furukori Norio, Yasushi Sato, Taku Nakagami, Shoko Tsuchimine, Ayako Kaneda, Sunao Kaneko
Neuropsychiatric disease and treatment 10 599 - 606 2014
-
Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals
Tsuchimine S, Yasui-Furukori N, Kaneda A, Kaneko S
PLos One 8 ( 11 ) 2013.11
-
Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
Kaneda A, Katagai T, Yasui-Furukori N
Neuropsychiatric disease and treatment 9 1203 - 1208 2013.8
-
Relationship between dietary patters and cognitive function in an community-dwelling population in japan
Sugawara N, Yasui-Furukori N, Umeda T, Tsuchimine S, Kaneda A, Tsuruga K, Iwane K, Okubo N, Takahashi I, Kaneko S
Asia-Pacific journal of public health / Asia-Pacific Academic Consortium for Public Health 2013.7
-
Association between plasma brain-derived neurotorophic factor levels and personality traits in healthy Japanese subjects
Yasui-Furukori N, Tsuchimine S, Kaneda A, Sugawara N, Ishioka M, Kaneko S
Psychiatry Research 210 ( 1 ) 220 - 223 2013.6
-
No association between a polymorphism in the serotonin receptor 2B(HTR2B) gene and personality traits in healthy Japanese subjects.
Tsuchimine S, Taniguchi T, Sugawara N, Kaneda A, Yasui-Furukori N.
Neuropsychobiology 68 ( 1 ) 59 - 62 2013.6